“The rating reflects our view of Palomar Health’s very strong enterprise profile combined with a vulnerable but improving financial profile,” said S&P analyst Martin Arrick.
The outlook is stable, reflecting S&P’s belief in Palomar Health management’s continued progress in restoring operational performance over the past few years.
More articles on healthcare finance:
Moody’s affirms Firelands Regional Medical Center’s ‘A3’ rating
S&P raises Yale New Haven Health Obligated Group’s ratings to ‘AA-‘
S&P assigns ‘AA’ rating to Texas Health Resources’ bonds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
